Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Orkla reports strong profit improvement

Orkla achieved EBIT (adj.) of NOK 2.1 billion in the third quarter of 2024, up 13% on the same period last year.Group operating revenues rose by 4.3% in the third quarter of 2024, year-over-year, and volume growth was positive for the third successive quarter. Orkla’s consolidated portfolio companies (including HQ and Business Service) grew EBIT (adj.) by 20%, to NOK 2.0 billion, in the third quarter of the year. The increase was broad-based across the consolidated portfolio companies, driven by organic revenue growth, margin improvement and positive mix effects. Adjusted earnings per

Presentation of 3[rd] quarter 2024 results

Key financials:  · Adjusted EBITDA in Solstad Offshore ASA of NOK 328 million and Solstad Maritime Holding AS of NOK 975 million · Solstad Maritime Holding AS initiates quarterly dividend payments from Q3 2024 of NOK 0.50/share, totaling NOK ~233 million. · Solstad Offshore’s share of the dividend amount is NOK ~64 million · High utilization of 97% in the quarter Skudeneshavn, Oct 29nd, 2024 Contacts Lars Peder Solstad CEO, at +47 91 31 85 85 Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASA www.solstad.com This information is subject of the

Eficode recognized as GitHub EMEA Channel Partner of the Year 2024 award winner

Helsinki, Finland, October 28, 2024 - Eficode, a leading DevOps company, has been awarded GitHub Channel of the Year in the EMEA Platform category at the prestigious GitHub Channel Partner of the Year Awards 2024. This award recognizes Eficode’s exceptional contributions, innovation, and dedication to delivering solutions that enable success for mutual customers within the GitHub ecosystem.This recognition underscores Eficode’s ongoing commitment to empowering organizations across Europe, United Kingdom, and the United States with innovative DevOps practices and seamless integration with

Read original

ShaMaran Reports Market Purchase and Cancellation of Bonds

VANCOUVER, BC, Oct. 28, 2024 /CNW/ - ShaMaran Petroleum Corp. (“ShaMaran” or the “Company”) (TSXV: SNM) (Nasdaq First North: SNM) announces the market purchase and cancellation of $2.1 million of the Company’s 12% senior unsecured bond (ISIN NO0011057622) (the “Bond”). The total outstanding amount of the Bond as of the date of this press release is $200.0 million.   ShaMaran plans to publish its financial statements for the nine months ending September 30, 2024, on November 7, 2024. Except as otherwise indicated, all currency amounts indicated as “$” in this news release are expressed

Rightbridge Ventures Group and Oceanview Announce Mutual Termination of Share Purchase Agreement - Claes Kalborg reinstated as CEO

Rightbridge Ventures Group AB (“Rightbridge”) and Oceanview Group Limited (“Oceanview”) jointly announce the mutual termination of their share purchase agreement, initially signed on June 24, 2024. This agreement, which involved Rightbridge’s acquisition of 51% of Oceanview, has been concluded based on a shared belief that the timing and strategic alignment are not optimal for either company. Thiago De Freitas steps down as CEO as part of the termination process and the board of directors has reinstated Claes Kalborg as CEO of Rightbridge Ventures Group.Both the board of directors in

Nordea Bank Abp: Repurchase of own shares on 28.10.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares28.10.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 28.10.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |139,754|10.90 |1,524,003.

CS MEDICA A/S: Notice of Extraordinary General Meeting

The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of an Extraordinary General Meeting to be held on Tuesday, 12 November 2024, at 15:00 via TEAMS.Proposed Agenda 1. Election of the chairman of the meeting. 2. Distribution of CANNORDIC Shares to CS MEDICA ShareholdersProposal to distribute 1 share in CANNORDIC for every 200 shares held by CS MEDICA shareholders as of the EGM date. Additionally, all shareholders will be offered the opportunity to purchase pre-IPO shares at a 20% discount. 3. Conversion of Receivables in CANNORDIC A/SProposal to

The Board of Loomis has resolved to continue to repurchase shares

The Board of Directors of Loomis AB has resolved to repurchase shares by virtue of the authorization granted by the Annual General Meeting 2024. The repurchase may commence on October 30, 2024, end no later than on December 20, 2024, and comprise an amount up to a maximum of SEK 200 million. Repurchase shall be made on Nasdaq Stockholm, on one or more occasions, at a price within the prevailing price interval registered at each point in time (being the interval between the highest buying price and the lowest selling price). Payment for repurchased shares shall be made in cash. Danske

Relais Group Plc: Share Repurchase 28.10.2024

Relais Group Plc  ANNOUNCEMENT  28.10.2024 Relais Group Plc: Share Repurchase 28.10.2024 In the Helsinki Stock Exchange Trade date           28.10.2024Bourse trade         BuyShare                  RELAISAmount             300 SharesAverage price/ share    14,6000 EURTotal cost            4 380,00 EUR Relais Group Plc now holds a total of 70 205 sharesincluding the shares repurchased on 28.10.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

Paragonix Technologies receives FDA 510(k) clearance for KidneyVault portable renal perfusion system

Paragonix Technologies, a leading organ preservation company recently acquired by Getinge, receives FDA clearance for the innovative transportable perfusion device KidneyVault, to optimize standard of care in kidney preservation.Getinge’s most recent acquisition, Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, has received US Food and Drug Administration (FDA) 510(k) clearance for its donor kidney preservation system, KidneyVault. The KidneyVault System is Paragonix’s first perfusion device, integrating its streamlined digital monitoring

Holding(s) in Company

TR-1: Standard form for notification of major holdings   NOTIFICATION OFMAJOR HOLDINGS(tobe sent to therelevant issuerandto the FCA inMicrosoft Wordformatif possible) i 1a. Identity of Zigup plcthe issuer or theunderlying issuerof existingsharesto which votingrights areattachedii:1b. Pleaseindicate if theissuer isa non-UK issuer (please markwithan “X” ifappropriate)Non-UK issuer  2. Reason for thenotification(please mark theappropriate boxorboxes with an

#24-370 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Dag Nykvist appointed Chair of Solwers Plc’s Shareholders’ Nomination Committee

Solwers Plc, Company Release, 28.10.2024 at 17:15 EET In its organising meeting on October 28, 2024, the Shareholders’ Nomination Committee of Solwers Plc elected Dag Nykvist as its Chair. The Shareholders’ Nomination Committee of Solwers Plc consists of representatives of the three largest shareholders, registered on September 2, 2024, as well as a board representative: · Leif Sebbas, Chair of the Board, nominated by FME Consulting Oy · Dag Nykvist, Managing Director, nominated by CEB Invest Oy · Erkka Kohonen, Senior Portfolio Manager, nominated by Varma Pension Insurance

Fiskars Corporation – Notification of management’s transactions – Siitonen

Fiskars CorporationManagers' transactionsOctober 28, 2024 at 5.05 p.m. EET Fiskars Corporation – Notification of management’s transactions – Siitonen Fiskars Corporation has received the following notification pursuant to Article 19 of the Market Abuse Regulation: Fiskars Corporation - Managers' transactions - Siitonen ____________________________________________ Person subject to the notification requirementName: Siitonen, JussiPosition: Chief Financial OfficerIssuer: Fiskars CorporationLEI: 743700BKTW4EQIVKYY42 Notification type: INITIAL NOTIFICATION

Fiskars Corporation – Notification of management’s transactions – Ahlström

Fiskars CorporationManagers' transactionsOctober 28, 2024 at 5.00 p.m. EET Fiskars Corporation – Notification of management’s transactions – Ahlström Fiskars Corporation has received the following notification pursuant to Article 19 of the Market Abuse Regulation: Fiskars Corporation - Managers' transactions - Ahlström ____________________________________________ Person subject to the notification requirementName: Ahlström, NathaliePosition: Chief Executive OfficerIssuer: Fiskars CorporationLEI: 743700BKTW4EQIVKYY42 Notification type: INITIAL NOTIFICATION

Form 8.3 - Zytronic PLC

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------+-------------------------------+|(a) Full name of discloser: |Henry Spain Investment Services|+----------------------------------------------+-------------------------------+|(b) Owner or controller of interests and short|  ||positions disclosed, if different from

ADDvise streamlines organization through new business area structure

To enhance focus and efficiency, ADDvise is restructuring its two existing business areas, Lab and Healthcare, into separate operational units, each led by a dedicated director. This new structure is designed to optimize the organization, establish a clearer strategic focus, and strengthen the foundation for both organic growth and acquisitions. Additionally, the structure facilitates valuable knowledge-sharing across the group. The Healthcare business area manufactures and supplies a diverse range of advanced medical technology, high-quality consumables, and pharmaceuticals. By

Nomination Committee for the 2025 Annual General Meeting

MilDef Group AB's Nomination Committee consists of the following members:· Johan Ståhl, appointed by Svolder AB (publ), Chair of the Nomination Committee · Marianne Trolle, representing her own ownership in MilDef · Martin Jonasson, appointed by Andra AP-fonden Furthermore, the Chair of the Board, Björn Karlsson, is co-opted to the Nomination Committee. Information about the Nomination Committee's work is available on MilDef's website Nomination Committee – MilDef Investors . Shareholders who

There are no items matching the current filter
There are no more items matching the current filter
Back to top